Vaccine Overview
rdESAT-6 and rCFP-10 (Cy-Tb) Injection (Detection of Latent-tuberculosis)
This diagnostic injection is used for detecting latent tuberculosis infection. It contains recombinant TB-specific antigens ESAT-6 and CFP-10, which are absent in BCG and most non-tuberculous mycobacteria. Injected intradermally, it triggers a local immune response in TB-infected individuals, allowing for accurate detection without false positives from BCG vaccination. It is an alternative to traditional tuberculin skin tests and is useful for screening high-risk populations, healthcare workers, and close contacts of TB patients.
Drug Class: Human Diagnostics
Indication: Detection of latent tuberculosis infection using specific antigens absent in BCG and NTM strains.
PREVENTS
Vaccine Details
Applied To
Infants, Children
Recommended Time
TB screening in high-risk or exposed individuals
Administration
Route: Intradermal
Site: Forearm (similar to tuberculin skin test site)
Disease
Latent Tuberculosis
Manufacturer
Serum Intitute Of India
Age
- ≥5 years (varies by country)
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025